Fenfluramine, a drug that was previously sold as an appetite suppressant before it was withdrawn from the market in 1997 over concerns about its link to heart valve problems, may have a new ...
Dravet syndrome affects around 1 in 15,700 children, and most cases are caused by mutations in the SCN1A gene. This gene ...
Stoke Therapeutics plans to provide an update regarding a global, randomized phase 3 registrational study by the end of the year. The Food and Drug Administration (FDA) has granted Breakthrough ...
SKYLINE Study in Dravet Syndrome Narrowly Missed its Primary Endpoint of Reduction in Convulsive Seizure Frequency and Showed Clinically Meaningful and Nominally Significant Effects in Multiple Key ...
View the original article about How CBD Can Be Beneficial In Treating Dravet Syndrome at CBD Drug Test Info. Even though CBD is shown to have a large number of health-promoting properties, not all of ...
Scientists from the Allen Institute and Seattle Children’s Research Institute have announced a breakthrough in the development of gene replacement therapies for Dravet syndrome, a rare form of ...
A scientific discovery may help children suffering from Dravet syndrome. Innovative gene therapy may help treat a severe and fatal developmental epilepsy syndrome that affects children. Researchers ...